Defining high-sensitivity cardiac troponin concentrations in the community

Paul McKie, Denise M. Heublein, Christopher G. Scott, Mary Lou Gantzer, Ramila A. Mehta, Richard J. Rodeheffer, Margaret May Redfield, John C Jr. Burnett, Allan S Jaffe

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

BACKGROUND: High-sensitivity cardiac troponin (hscTn) assays are now available that can detect measurable troponin in significantly more individuals in the general population than conventional assays. The clinical use of these hs-cTn assays depends on the development of proper reference values. Therefore, our objective was to define hs-cTnI reference values and determinants in the general community, in a healthy reference cohort, and in subsets with diseases. MATERIALS AND METHODS: A well-characterized community-based cohort of 2042 study participants underwent clinical assessment and echocardiographic evaluation. Baseline hs-cTnI measurements were obtained in 1843 individuals. A healthy reference cohort (n = 565) without cardiac, renal, or echocardiographic abnormalities was identified. RESULTS: Measurable hs-cTnI was identified in 1716 (93%) of the community-based study cohort and 499 (88%) of the healthy reference cohort. Parameters that significantly contributed to higher hs-cTnI concentrations in the healthy reference cohort included age, male sex, systolic blood pressure, and left ventricular mass. Glomerular filtration rate and body mass index were not independently associated with hs-cTnI in the healthy reference cohort. Individuals with diastolic and systolic dysfunction, hypertension, and coronary artery disease (but not impaired renal function) had significantly higher hs-cTnI values than the healthy reference cohort. CONCLUSIONS: We assessed an hs-cTnI assay with the aid of echocardiographic imaging in a large, well-characterized community-based cohort. hs-cTnI is remarkably sensitive in the general population, and there are important sex and age differences among healthy reference individuals. These results have important implications for defining hs-cTnI reference values and identifying disease.

Original languageEnglish (US)
Pages (from-to)1099-1107
Number of pages9
JournalClinical Chemistry
Volume59
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Troponin
Assays
Reference Values
Cohort Studies
Blood Pressure
Kidney
Blood pressure
Glomerular Filtration Rate
Sex Characteristics
Population
Coronary Artery Disease
Body Mass Index
Hypertension
Imaging techniques

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

McKie, P., Heublein, D. M., Scott, C. G., Gantzer, M. L., Mehta, R. A., Rodeheffer, R. J., ... Jaffe, A. S. (2013). Defining high-sensitivity cardiac troponin concentrations in the community. Clinical Chemistry, 59(7), 1099-1107. https://doi.org/10.1373/clinchem.2012.198614

Defining high-sensitivity cardiac troponin concentrations in the community. / McKie, Paul; Heublein, Denise M.; Scott, Christopher G.; Gantzer, Mary Lou; Mehta, Ramila A.; Rodeheffer, Richard J.; Redfield, Margaret May; Burnett, John C Jr.; Jaffe, Allan S.

In: Clinical Chemistry, Vol. 59, No. 7, 07.2013, p. 1099-1107.

Research output: Contribution to journalArticle

McKie P, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clinical Chemistry. 2013 Jul;59(7):1099-1107. https://doi.org/10.1373/clinchem.2012.198614
McKie, Paul ; Heublein, Denise M. ; Scott, Christopher G. ; Gantzer, Mary Lou ; Mehta, Ramila A. ; Rodeheffer, Richard J. ; Redfield, Margaret May ; Burnett, John C Jr. ; Jaffe, Allan S. / Defining high-sensitivity cardiac troponin concentrations in the community. In: Clinical Chemistry. 2013 ; Vol. 59, No. 7. pp. 1099-1107.
@article{1fe6132709e74e00b5eee4e7d78b6593,
title = "Defining high-sensitivity cardiac troponin concentrations in the community",
abstract = "BACKGROUND: High-sensitivity cardiac troponin (hscTn) assays are now available that can detect measurable troponin in significantly more individuals in the general population than conventional assays. The clinical use of these hs-cTn assays depends on the development of proper reference values. Therefore, our objective was to define hs-cTnI reference values and determinants in the general community, in a healthy reference cohort, and in subsets with diseases. MATERIALS AND METHODS: A well-characterized community-based cohort of 2042 study participants underwent clinical assessment and echocardiographic evaluation. Baseline hs-cTnI measurements were obtained in 1843 individuals. A healthy reference cohort (n = 565) without cardiac, renal, or echocardiographic abnormalities was identified. RESULTS: Measurable hs-cTnI was identified in 1716 (93{\%}) of the community-based study cohort and 499 (88{\%}) of the healthy reference cohort. Parameters that significantly contributed to higher hs-cTnI concentrations in the healthy reference cohort included age, male sex, systolic blood pressure, and left ventricular mass. Glomerular filtration rate and body mass index were not independently associated with hs-cTnI in the healthy reference cohort. Individuals with diastolic and systolic dysfunction, hypertension, and coronary artery disease (but not impaired renal function) had significantly higher hs-cTnI values than the healthy reference cohort. CONCLUSIONS: We assessed an hs-cTnI assay with the aid of echocardiographic imaging in a large, well-characterized community-based cohort. hs-cTnI is remarkably sensitive in the general population, and there are important sex and age differences among healthy reference individuals. These results have important implications for defining hs-cTnI reference values and identifying disease.",
author = "Paul McKie and Heublein, {Denise M.} and Scott, {Christopher G.} and Gantzer, {Mary Lou} and Mehta, {Ramila A.} and Rodeheffer, {Richard J.} and Redfield, {Margaret May} and Burnett, {John C Jr.} and Jaffe, {Allan S}",
year = "2013",
month = "7",
doi = "10.1373/clinchem.2012.198614",
language = "English (US)",
volume = "59",
pages = "1099--1107",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "7",

}

TY - JOUR

T1 - Defining high-sensitivity cardiac troponin concentrations in the community

AU - McKie, Paul

AU - Heublein, Denise M.

AU - Scott, Christopher G.

AU - Gantzer, Mary Lou

AU - Mehta, Ramila A.

AU - Rodeheffer, Richard J.

AU - Redfield, Margaret May

AU - Burnett, John C Jr.

AU - Jaffe, Allan S

PY - 2013/7

Y1 - 2013/7

N2 - BACKGROUND: High-sensitivity cardiac troponin (hscTn) assays are now available that can detect measurable troponin in significantly more individuals in the general population than conventional assays. The clinical use of these hs-cTn assays depends on the development of proper reference values. Therefore, our objective was to define hs-cTnI reference values and determinants in the general community, in a healthy reference cohort, and in subsets with diseases. MATERIALS AND METHODS: A well-characterized community-based cohort of 2042 study participants underwent clinical assessment and echocardiographic evaluation. Baseline hs-cTnI measurements were obtained in 1843 individuals. A healthy reference cohort (n = 565) without cardiac, renal, or echocardiographic abnormalities was identified. RESULTS: Measurable hs-cTnI was identified in 1716 (93%) of the community-based study cohort and 499 (88%) of the healthy reference cohort. Parameters that significantly contributed to higher hs-cTnI concentrations in the healthy reference cohort included age, male sex, systolic blood pressure, and left ventricular mass. Glomerular filtration rate and body mass index were not independently associated with hs-cTnI in the healthy reference cohort. Individuals with diastolic and systolic dysfunction, hypertension, and coronary artery disease (but not impaired renal function) had significantly higher hs-cTnI values than the healthy reference cohort. CONCLUSIONS: We assessed an hs-cTnI assay with the aid of echocardiographic imaging in a large, well-characterized community-based cohort. hs-cTnI is remarkably sensitive in the general population, and there are important sex and age differences among healthy reference individuals. These results have important implications for defining hs-cTnI reference values and identifying disease.

AB - BACKGROUND: High-sensitivity cardiac troponin (hscTn) assays are now available that can detect measurable troponin in significantly more individuals in the general population than conventional assays. The clinical use of these hs-cTn assays depends on the development of proper reference values. Therefore, our objective was to define hs-cTnI reference values and determinants in the general community, in a healthy reference cohort, and in subsets with diseases. MATERIALS AND METHODS: A well-characterized community-based cohort of 2042 study participants underwent clinical assessment and echocardiographic evaluation. Baseline hs-cTnI measurements were obtained in 1843 individuals. A healthy reference cohort (n = 565) without cardiac, renal, or echocardiographic abnormalities was identified. RESULTS: Measurable hs-cTnI was identified in 1716 (93%) of the community-based study cohort and 499 (88%) of the healthy reference cohort. Parameters that significantly contributed to higher hs-cTnI concentrations in the healthy reference cohort included age, male sex, systolic blood pressure, and left ventricular mass. Glomerular filtration rate and body mass index were not independently associated with hs-cTnI in the healthy reference cohort. Individuals with diastolic and systolic dysfunction, hypertension, and coronary artery disease (but not impaired renal function) had significantly higher hs-cTnI values than the healthy reference cohort. CONCLUSIONS: We assessed an hs-cTnI assay with the aid of echocardiographic imaging in a large, well-characterized community-based cohort. hs-cTnI is remarkably sensitive in the general population, and there are important sex and age differences among healthy reference individuals. These results have important implications for defining hs-cTnI reference values and identifying disease.

UR - http://www.scopus.com/inward/record.url?scp=84879715146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879715146&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2012.198614

DO - 10.1373/clinchem.2012.198614

M3 - Article

C2 - 23592511

AN - SCOPUS:84879715146

VL - 59

SP - 1099

EP - 1107

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7

ER -